Nature Reviews Clinical Oncology, Published online: 17 May 2024; doi:10.1038/s41571-024-00904-zLessons from the prevention of cervical cancer, the first cancer type deemed amenable to elimination, can provide information on strategies to manage other cancers. Infection with human papillomavirus (HPV) causes virtually all cervical cancers and an important...

Nature Reviews Clinical Oncology, Published online: 17 May 2024; doi:10.1038/s41571-024-00902-1Following their successful implementation in the COVID-19 pandemic, the technology behind mRNA vaccines is now being applied to cancer. In this Review, the authors described the several decades of development of mRNA vaccines for patients with cancer, including...

Nature Reviews Clinical Oncology, Published online: 07 May 2024; doi:10.1038/s41571-024-00898-8The question of whether chimeric antigen receptor (CAR) T cell therapies should be used in earlier lines (after 1–2 prior lines of therapy) in patients with relapsed and/or refractory multiple myeloma remains unanswered. Herein, I argue that the use of surrogate...

Nature Reviews Clinical Oncology, Published online: 01 May 2024; doi:10.1038/s41571-024-00892-0Expansion of the utilizable spectrum of light from the visible region to the near-infrared (NIR) window has greatly facilitated the clinical application of optical technologies for cancer imaging and phototherapy. However, use of light in the first NIR region...

Nature Reviews Clinical Oncology, Published online: 29 April 2024; doi:10.1038/s41571-024-00901-2Adjuvant pembrolizumab improves overall survival in patients with RCC

Nature Reviews Clinical Oncology, Published online: 29 April 2024; doi:10.1038/s41571-024-00900-3Laparoscopic hemihepatectomy is safe and effective